Phosphatidylserine-Targeting Nanobody Chimeras

Mechanistic description

Nanobodies engineered with phosphatidylserine-binding domains could selectively penetrate vesicles containing aggregated tau, as pathological tau aggregation disrupts membrane asymmetry and exposes PS on the inner leaflet.

Mechanism / pathway

MAPT
→
molecular biology

Evidence for (5)

Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules.

PMID:27940599 2017 Cold Spring Harb Perspect Med
MAPT mutations, tauopathy, and mechanisms of neurodegeneration.

PMID:30742061 2019 Lab Invest
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial.

PMID:37095250 2023 Nat Med
Tau filaments with the Alzheimer fold in human MAPT mutants V337M and R406W.

PMID:40044789 2025 Nat Struct Mol Biol
Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.

PMID:36066634 2022 Acta Neuropathol

Evidence against (3)

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies.

PMID:31564456 2019 Cell
Synergy between amyloid-β and tau in Alzheimer's disease.

PMID:32778792 2020 Nat Neurosci
Cellular and pathological functions of tau.

PMID:39014245 2024 Nat Rev Mol Cell Biol

Evidence matrix

5 supporting 3 contradicting

63% supporting

Supporting

Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules. PMID:27940599 · 2017 · Cold Spring Harb Perspect Med
MAPT mutations, tauopathy, and mechanisms of neurodegeneration. PMID:30742061 · 2019 · Lab Invest
Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial. PMID:37095250 · 2023 · Nat Med
Tau filaments with the Alzheimer fold in human MAPT mutants V337M and R406W. PMID:40044789 · 2025 · Nat Struct Mol Biol
Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration. PMID:36066634 · 2022 · Acta Neuropathol

Contradicting

Alzheimer Disease: An Update on Pathobiology and Treatment Strategies. PMID:31564456 · 2019 · Cell
Synergy between amyloid-β and tau in Alzheimer's disease. PMID:32778792 · 2020 · Nat Neurosci
Cellular and pathological functions of tau. PMID:39014245 · 2024 · Nat Rev Mol Cell Biol

Cite this hypothesis

Citation

etl-backfill (2026). Phosphatidylserine-Targeting Nanobody Chimeras. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-3

BibTeX

@misc{scidex_hypothesis_hypsda20,
  title        = {Phosphatidylserine-Targeting Nanobody Chimeras},
  author       = {etl-backfill},
  year         = {2026},
  howpublished = {SciDEX hypothesis},
  url          = {https://prism.scidex.ai/hypotheses/hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-3},
  note         = {SciDEX artifact hypothesis:hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-3}
}